Oturkar, C.C.; Gandhi, N.; Rao, P.; Eng, K.H.; Miller, A.; Singh, P.K.; Zsiros, E.; Odunsi, K.O.; Das, G.M.
Correction: Oturkar et al. Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC). Cancers 2022, 14, 1120. Cancers 2026, 18, 2360.
https://doi.org/10.3390/cancers18142360
AMA Style
Oturkar CC, Gandhi N, Rao P, Eng KH, Miller A, Singh PK, Zsiros E, Odunsi KO, Das GM.
Correction: Oturkar et al. Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC). Cancers 2022, 14, 1120. Cancers. 2026; 18(14):2360.
https://doi.org/10.3390/cancers18142360
Chicago/Turabian Style
Oturkar, Chetan C., Nishant Gandhi, Pramod Rao, Kevin H. Eng, Austin Miller, Prashant K. Singh, Emese Zsiros, Kunle O. Odunsi, and Gokul M. Das.
2026. "Correction: Oturkar et al. Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC). Cancers 2022, 14, 1120" Cancers 18, no. 14: 2360.
https://doi.org/10.3390/cancers18142360
APA Style
Oturkar, C. C., Gandhi, N., Rao, P., Eng, K. H., Miller, A., Singh, P. K., Zsiros, E., Odunsi, K. O., & Das, G. M.
(2026). Correction: Oturkar et al. Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC). Cancers 2022, 14, 1120. Cancers, 18(14), 2360.
https://doi.org/10.3390/cancers18142360
